Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 80,764 | 57,728 | 34,842 | 65,582 | 9,551 |
| Cost of Goods | 8,097 | 5,257 | 5,772 | 2,597 | 1,601 |
| Gross Profit | 72,667 | 52,471 | 29,070 | 62,985 | 7,950 |
| Operating Expenses | 69,139 | 74,800 | 46,937 | 16,044 | 50,158 |
| Operating Income | 3,625 | -22,072 | -17,095 | 47,538 | -41,607 |
| Interest Expense | 572 | 1,001 | 555 | 0 | 0 |
| Other Income | 839 | 1,050 | 2,349 | 2,273 | 2,031 |
| Pre-tax Income | 3,892 | -22,023 | -15,301 | 49,811 | -39,576 |
| Income Tax | -4 | -15 | 1 | 592 | 83 |
| Net Income Continuous | 3,896 | -22,008 | -15,302 | 49,219 | -39,659 |
| Net Income | $3,896 | $-22,008 | $-15,302 | $49,219 | $-39,659 |
| EPS Basic Total Ops | 4.20 | -25.79 | -19.19 | 63.57 | -58.17 |
| EPS Basic Continuous Ops | 4.45 | -25.62 | -18.81 | 64.24 | -57.28 |
| EPS Diluted Total Ops | 4.20 | -25.79 | -19.19 | 62.97 | -58.17 |
| EPS Diluted Continuous Ops | 4.37 | -25.62 | -18.81 | 63.68 | -57.28 |
| EBITDA(a) | $4,064 | $-21,264 | $-15,947 | $48,403 | $-40,227 |